Investment case
Exosens
EXSNY · 2 developments mapped · last assessed 2026-09-17
Market Ontology has mapped 2 macro, policy, and market developments to Exosens since 2026-09-17. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for EXSNY yet, so no modelled value is shown. The EXSNY valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run EXSNY on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
Exosens Raises 2026 Revenue and EBITDA Outlook on Production Ramp
Direct financial guidance upgrade reflecting stronger-than-expected operational performance and demand.
· Moves future revenue growth rates, ebitda margins, discounted cash flow projections
What changed, by assumption
- 2026-09-17Exosens Raises 2026 Revenue and EBITDA Outlook on Production Ramp
- 2026-09-17Exosens Raises 2026 Revenue and EBITDA Guidance on Defense Production Ramp
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-17 | Exosens Raises 2026 Revenue and EBITDA Outlook on Production Ramp | Bullish | 1-3m | 0.90 |
| 2026-09-17 | Exosens Raises 2026 Revenue and EBITDA Guidance on Defense Production Ramp | Bullish | 1-3m | 0.90 |